Anika Therapeutics, Inc. (ANIK) Net margin 2016–2025
Anika Therapeutics, Inc. (ANIK) net profit margin by fiscal year — reported net income divided by reported revenue.
-9.8%FY2025 · since FY2016: 31.5% → -9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.8% | +37.0 pp |
| FY2024 | -46.7% | +22.0 pp |
| FY2023 | -68.7% | -55.5 pp |
| FY2022 | -13.2% | -15.9 pp |
| FY2021 | 2.7% | +21.1 pp |
| FY2020 | -18.4% | -42.1 pp |
| FY2019 | 23.7% | +6.0 pp |
| FY2018 | 17.7% | -10.3 pp |
| FY2017 | 28.1% | -3.4 pp |
| FY2016 | 31.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice